These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11166405)

  • 1. Simultaneous delivery of an active protein and neutralizing antibody: creation of separated regions of biological activity.
    Fleming AB; Saltzman WM
    J Control Release; 2001 Jan; 70(1-2):29-36. PubMed ID: 11166405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silk fibroin matrices for the controlled release of nerve growth factor (NGF).
    Uebersax L; Mattotti M; Papaloïzos M; Merkle HP; Gander B; Meinel L
    Biomaterials; 2007 Oct; 28(30):4449-60. PubMed ID: 17643485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of the controlled release of nerve growth factor from collagen gel on the efficiency of neural cell culture.
    Bhang SH; Lee TJ; Lim JM; Lim JS; Han AM; Choi CY; Kwon YH; Kim BS
    Biomaterials; 2009 Jan; 30(1):126-32. PubMed ID: 18838157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled release of nerve growth factor from fibrin gel.
    Bhang SH; Jeon O; Choi CY; Kwon YH; Kim BS
    J Biomed Mater Res A; 2007 Mar; 80(4):998-1002. PubMed ID: 17117469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of cell type and density on nerve growth factor distribution and bioactivity in 3-dimensional collagen gel cultures.
    Mahoney MJ; Krewson C; Miller J; Saltzman WM
    Tissue Eng; 2006 Jul; 12(7):1915-27. PubMed ID: 16889521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transport and elimination of recombinant human NGF during long-term delivery to the brain.
    Krewson CE; Saltzman WM
    Brain Res; 1996 Jul; 727(1-2):169-81. PubMed ID: 8842395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologic activity of nerve growth factor slowly released from microspheres.
    Hadlock TA; Sheahan T; Cheney ML; Vacanti JP; Sundback CA
    J Reconstr Microsurg; 2003 Apr; 19(3):179-84; discussion 185-6. PubMed ID: 12806579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release rate controls biological activity of nerve growth factor released from fibrin matrices containing affinity-based delivery systems.
    Wood MD; Sakiyama-Elbert SE
    J Biomed Mater Res A; 2008 Feb; 84(2):300-12. PubMed ID: 17607752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mesoporous silica nanosphere-based drug delivery system using an electrically conducting polymer.
    Cho Y; Shi R; Ivanisevic A; Ben Borgens R
    Nanotechnology; 2009 Jul; 20(27):275102. PubMed ID: 19528680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and evaluation of NGF-microsphere conduits for regeneration of defective nerves.
    Sun H; Xu F; Guo D; Yu H
    Neurol Res; 2012 Jun; 34(5):491-7. PubMed ID: 22642924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyphosphoester microspheres for sustained release of biologically active nerve growth factor.
    Xu X; Yu H; Gao S; Ma HQ; Leong KW; Wang S
    Biomaterials; 2002 Sep; 23(17):3765-72. PubMed ID: 12109702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth arrest of PC12 cells by nerve growth factor is dependent on the phosphatidylinositol 3-kinase/Akt pathway via p75 neurotrophin receptor.
    Ito H; Nomoto H; Furukawa S
    J Neurosci Res; 2003 Apr; 72(2):211-7. PubMed ID: 12671996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemically-bound nerve growth factor for neural tissue engineering applications.
    Kapur TA; Shoichet MS
    J Biomater Sci Polym Ed; 2003; 14(4):383-94. PubMed ID: 12747676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralizing intraspinal nerve growth factor with a trkA-IgG fusion protein blocks the development of autonomic dysreflexia in a clip-compression model of spinal cord injury.
    Marsh DR; Wong ST; Meakin SO; MacDonald JI; Hamilton EF; Weaver LC
    J Neurotrauma; 2002 Dec; 19(12):1531-41. PubMed ID: 12542855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo induction and delivery of nerve growth factor, using HEK-293 cells.
    McConnell MP; Dhar S; Naran S; Nguyen T; Bradshaw RA; Evans GR
    Tissue Eng; 2004; 10(9-10):1492-501. PubMed ID: 15588408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled nerve growth factor release from multi-ply alginate/chitosan-based nerve conduits.
    Pfister LA; Alther E; Papaloïzos M; Merkle HP; Gander B
    Eur J Pharm Biopharm; 2008 Jun; 69(2):563-72. PubMed ID: 18294826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nerve conduits based on immobilization of nerve growth factor onto modified chitosan by using genipin as a crosslinking agent.
    Yang Y; Zhao W; He J; Zhao Y; Ding F; Gu X
    Eur J Pharm Biopharm; 2011 Nov; 79(3):519-25. PubMed ID: 21736941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of nerve growth factor following direct delivery to brain interstitium.
    Krewson CE; Klarman ML; Saltzman WM
    Brain Res; 1995 May; 680(1-2):196-206. PubMed ID: 7663977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Balance of two secretion pathways of nerve growth factor in PC12 cells changes during the progression of their differentiation, with a decrease in constitutive secretion in more differentiated cells.
    Nomoto H; Tomotoshi K; Ito H; Furukawa S
    J Neurosci Res; 2000 Mar; 59(5):632-42. PubMed ID: 10686591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nerve growth factor- and epidermal growth factor-regulated gene transcription in PC12 pheochromocytoma and INS-1 insulinoma cells.
    Groot M; Boxer LM; Thiel G
    Eur J Cell Biol; 2000 Dec; 79(12):924-35. PubMed ID: 11152283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.